FiercePharma10d
FDA's Patrizia Cavazzoni to retire as CDER chief in 2nd senior official's departure in span of weeks
The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire ...
STAT8d
Patrizia Cavazzoni, head of FDA’s drug center, to leave the agency
Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.
Hosted on MSN9d
FDA CDER director Patrizia Cavazzoni announces resignation
Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.
FDA Unveils Grounds For Rejecting Vanda Pharmaceuticals Stomach Paralysis Candidate
The Director of the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA) issued a ...
FiercePharma3d
Government watchdog recommends tweaks to FDA accelerated approval program
The FDA established its accelerated approval program in 1992 to allow drugs to reach the market quickly for life-threatening ...
BioPharma Dive9d
Patrizia Cavazzoni, key FDA official, to leave agency
The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is ...
Staten Island Advance24d
FDA to phase out decongestant found in over-the-counter medicines: It doesn’t work
An active ingredient in popular cold and cough medicines is in the process of being phased out due to concerns over its efficacy. Last month, the U.S. Food and Drug Administration proposed ...
Nature18d
2024 FDA approvals
The FDA’s Center for Drug Evaluation and Research (CDER) approved 50 new small molecules, biologics and oligonucleotide therapeutics last year. The class of 2024 was a little smaller than that ...
Medscape3d
Role of FDA's Drug Information Centers
LCDR Kavita C. Dada, Pharm.D., USPHS; CDR Mary E. Kremzner, Pharm.D., USPHS; Sanjeev K. Bhanot, Pharm.D.; Renu Lal, Pharm.D. A: The mission of CBER is to protect and ...